ReviewThe Lancet. Respiratory medicine2025

Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trials.

Nicole Mayer-Hamblett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.